{
  "docId": "019de073-bfd4-723b-805d-c3152d3a00ff",
  "docSlug": "7df1d9bdbc08777b7243fabbc766ed39",
  "documentTitle": "Immatics | Results Presentation Deck | 25 slides",
  "authorId": "immatics",
  "authorName": "Immatics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7860465,
  "pageNumber": 6,
  "pageCount": 25,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "before_after",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a before-after framework to contrast the focus areas of two clinical trial phases, followed by a numbered list of specific improvements.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-bfd4-723b-805d-c3152d3a00ff/6",
  "deckHref": "/decks/019de073-bfd4-723b-805d-c3152d3a00ff",
  "deckJsonHref": "/decks/019de073-bfd4-723b-805d-c3152d3a00ff.json",
  "deckAnchorHref": "/decks/019de073-bfd4-723b-805d-c3152d3a00ff#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.26,
        "w": 0.78,
        "x": 0.11,
        "y": 0.21
      },
      "kind": "framework",
      "text": "Comparison of Phase 1a and Phase 1b focus areas",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7585fb9-09ae-4991-81aa-b7a0b44bf594",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.03,
        "y": 0.6
      },
      "kind": "list",
      "text": "1. Higher T cell dose: Only RP2D or exploratory DL5\n2. Enhanced cell product: Implementation of manufacturing enhancements (e.g. monocyte depletion, see appendix) focusing on robustness, quality, and speed of product release\n3. \"Real life\" patients: Working with more disease area experts to reduce the fraction of very heavily pre-treated patients with extreme disease burden who have exhausted standard of care and have undergone multiple clinical trials",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07af39ca-dc7b-43f9-a5e3-0594b1c3620f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.03,
        "y": 0.54
      },
      "kind": "paragraph",
      "text": "We continue to improve key determinants as we move from Phase 1a into Phase 1b",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b9fcd9a6-8396-4c3e-ac1f-92cb171b205e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.03,
        "y": 0.11
      },
      "kind": "title",
      "text": "Continuous Improvement of Key Aspects that May Influence Clinical Outcome",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43080df0-4348-4163-8372-04b1b7ac00cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.35,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Moving from Phase 1a to Phase 1b",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a18b1d98-e8a9-4fb2-9581-15298212c693",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "60779013-139f-4c82-a07b-955e8c661b7e",
      "evidence": "Moving from Phase 1a to Phase 1b",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "93265b12-497e-41af-b880-259ffffa2fd2",
      "evidence": "The slide explicitly contrasts Phase 1a and Phase 1b focus areas using a visual transition arrow.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 8,
      "from": 6,
      "beatId": "f87ff3c7-beb2-4ef5-9bba-04a71182565f",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "Slides 6-8 highlight the limitations of current therapies and the need for improvement.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 6,
      "name": "Before After",
      "slug": "21-before-after",
      "bestFor": "Product demos, process improvements, ROI justification",
      "matchId": "f1808ddc-c99c-471d-823a-31b9839269d3",
      "evidence": "Slides 6 and 15 show the before and after comparison.",
      "position": 0,
      "objective": "Show improvement from Phase 1a to Phase 1b",
      "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
      "confidence": 0.7,
      "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}